Cardiovascular disease, including heart disease and stroke, is the major cause of death worldwide and many drugs have been developed to eliminate unwanted blood clots. We perform contract testing on streptokinase and other thrombolytic plasminogen activators used as “clot busters” , for example tissue plasminogen activator and derivatives, to treat myocardial infarction (heart attack) and ischaemic stroke.